Human semi-quantitative apoptosis antibody arrays are multiplex protein profiling tools used to investigate apoptosis-related signalling pathways in human biological samples. These antibody microarrays consist of capture antibodies immobilised at defined positions on glass slides. In sandwich-based formats, target proteins are captured by specific antibodies and detected using complementary detection antibodies and compatible signal-generating reagents. Fluorescence signals are measured with a compatible microarray scanner to compare relative protein abundance between experimental conditions.
Key Features
Multiplex protein detection: Simultaneous analysis of multiple apoptosis-associated proteins on a single glass slide.
Pathway profiling: Investigation of proteins associated with pro-apoptotic and anti-apoptotic signalling.
Semi-quantitative analysis: Comparison of relative protein abundance across samples under appropriately controlled experimental conditions.
Fluorescence-based detection: Signal acquisition and analysis using compatible microarray scanners and software.
Usual Applications
Human apoptosis antibody arrays support research into programmed cell death, cancer biology and cellular responses to experimental treatments. They can help researchers investigate changes in apoptosis-associated protein profiles following drug exposure, genetic manipulation or other experimental stimuli. Comparative profiling can also guide the selection of candidate proteins for subsequent validation using complementary techniques, such as Western blotting or immunoassays.
These arrays provide an exploratory overview of apoptosis-associated protein profiles but do not independently establish apoptotic activity or pathway function.
